Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHANGHAI SHENQI PHARM INVEST MA) aksje
600613.SS
StengtSHANGHAI SHENQI PHARM INVEST MA
Market Cap
$2,761,150,208
Om Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHANGHAI SHENQI PHARM INVEST MA) aksje
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.
Selskapsinformasjon
200003 Shanghai, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.